Contact Us
Email Us: Customer Service
Phone (US): 703-778-3080
Fax: 703-778-3081
-
Pay Invoice
Follow Us!
Latest Blogs
- How Market Research Supercharges Laboratory Diagnostics Go-To-Market Strategies April 24, 2024
- 4 Key Components to a Winning Go-To-Market Strategy April 24, 2024
- Immunoassays: A $27 Billion Market of Intrigue and Opportunity April 12, 2024
- IVD in Egypt: $440 Million Market Lead by Immunodiagnostic and Molecular Diagnostic Growth April 11, 2024
- Momentum in Multiplex Testing for IVD April 1, 2024
Sitemap
Your Data and Privacy
About Us
Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.
Visit Science and Medicine Group
Visit Science and Medicine Group
This Week in Cell and Gene Therapy: 12 New Developments to Know (June 13, 2022)
The Middle East and Africa Region a $4 Billion Hotbed for IVD Investment
Globally, in vitro diagnostic (IVD) companies are exploring opportunities in developing countries, where rising incomes and standards of living have sparked a new health consciousness and growing demands for quality medical care. As the COVID-19 dust settles, it is expected that the interest in geographic expansion will once again return to the Middle East and […]
Single Cell Genomics in Next-Generation Sequencing (NGS) Market Reaches $780 Million
VIDEO: 5 Key Facts about Point-of-Care (POC) Diagnostic Tests
Learn about these 5 key facts based on research featured in The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 9th Edition (published April 2022), a recent report by Kalorama Information Watch the one minute video below for insights and important facts regarding the POC diagnostic testing market. And as always, Kalorama Information offers even more […]
AACC Calls on Congress to Halt Legislation That Would Hinder Patient Access to Essential Medical Tests
WASHINGTON – AACC has sent comments to the U.S. Senate Health, Education, Labor & Pensions (HELP) Committee urging the committee not to include the VALID Act in its omnibus Food and Drug Administration (FDA) user fee legislation. VALID would limit the availability of vital laboratory-developed tests, decreasing patient access to life-saving diagnostic tools. View the comments […]
This Week in Cell and Gene Therapy: 14 New Developments to Know (May 23, 2022)
Pandemic Pushes Rx To OTC Switches
The U.S. Rx-to-OTC market has grown into a $13,807 million ($13.8 billion) market, according to 2021 estimates by leading medical market researcher Kalorama Information in the new report The Market for Rx-to-OTC Switches, 8th Edition. This has mainly been due to factors such as patent expirations, increasing competitiveness with the pharmaceutical environment, the FDA willingness […]
This week in Cell and Gene Therapy: 14 New Developments to Know (May 9, 2022)
There have been a number of recent developments in cell and gene therapy, as detailed in our bimonthly newsletter, Cell and Gene Therapy Business Outlook. The U.S. FDA has lifted clinical holds on two Phase III clinical studies evaluating gene therapies being developed by Pfizer, based in New York, NY. On April 28th, Pfizer announced […]
COVID-19 Test Market: $33BN in Revenues in 2021, Future Still a Guess
Kalorama has just completed a report on the COVID-19 in vitro diagnostic testing market. 2021 was a year in which point-of-care antigen tests, lab-based PCR tests, rapid PCR and even home tests were available to the market. Also antibody tests, NGS tests and other tests were brought to bear in diagnosing cases. The scourge of […]
Point-of-Care (POC) Diagnostic Testing: 5 Key Trends to Watch from 2022-2026
Globally, millions of dollars are spent annually on point-of-care (POC) diagnostic testing, both professional testing (which includes physician office labs, clinic labs, employer labs and hospital labs) and self-testing (which includes home, drug store testing and continuous glucose testing). In 2021, amidst the pandemic, the POC market reached $41,149 million ($41.1 billion) and the market […]